𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Physical activity as a negative modulator of estrogen-induced breast cancer

✍ Scribed by Yvonne M. Coyle


Publisher
Springer Netherlands
Year
2008
Tongue
English
Weight
252 KB
Volume
19
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Interleukin-8 modulates growth and invas
✍ Chen Yao; Ying Lin; Mei-Sze Chua; Cai-Sheng Ye; Jiong Bi; Wen Li; Yi-Fan Zhu; Sh πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 439 KB

## Abstract Breast cancer, especially estrogen receptor (ER)‐negative breast cancer, remains hard to treat despite major advances in surgery and adjuvant therapies. The deletion of ER has been consistently associated with tumor progression, recurrence, metastasis and poor prognosis. Among other dif

Overexpression of histone deacetylase HD
✍ Hideki Kawai; Huchun Li; Shalom Avraham; Shuxian Jiang; Hava Karsenty Avraham πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 241 KB

## Abstract The interaction between 17β‐estradiol and estrogen receptor alpha (ER‐α) plays an important role in breast carcinogenesis and breast cancer treatment. ER‐α is a critical growth regulatory gene in breast cancer and its expression level is tightly linked to the prognosis and treatment out

Expression of estrogen receptor alpha in
✍ Nadine A. Binai; Annette Damert; Gert Carra; Stephan Steckelbroeck; Johannes LΓΆw πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 816 KB

## Abstract Adipositas correlates with an enhanced risk of developing malignant diseases such as breast cancer, endometrial tumor or prostate carcinoma, but the molecular basis for this is not well understood. Potential mechanisms include increased bioavailability of adipocytokines (__e.g.__ leptin

Estrogen receptor protein of breast canc
✍ John A. Butler; Sara Bretsky; Celia Menendez-Botet; David W. Kinne πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 2 views

To assess the value of estrogen receptor protein (ERP) as a predictor of tumor recurrence, 556 patients treated by mastectomy between 1973 and 1978 for primary operable breast cancer had ERP determination of their tumors. All patients had histologically negative nodes. Two hundred fifty-six patients